The effect of supportive E. coli mastitis treatment on PMN chemiluminescence and subpopulations of T lymphocytes

• Autorzy: Markiewicz H. , Krumrych W. , Gehrke M.
• Języki publikacji: EN

Abstrakty

EN

The aim of this field study was to assess the impact of a single i.m. injection of lysozyme dimer and flunixin meglumine in combination with intramammary and systemic antibiotic on chemiluminescence of PMN (polymorphonuclear leucocytes) and subpopulations of lymphocyte T in blood of cows with E. coli mastitis. Examinations were performed on 30 dairy cows affected with naturally occurring acute form of E. coli mastitis. Cows were randomly divided into three groups according to the method of treatment. The first group was treated with approved intramammary antibiotic product, the same antibiotic in i.m. injection and one injection of flunixin meglumine on the first day of therapy. Next group was treated with the same antibiotic and additionally one injection of lysozyme dimer on the first day of therapy. The third one was treated only with an antibiotic and served as a control group. Blood samples were taken before treatment and on days 3 and 7. In samples haematology indices were determined, spontaneous and opsonised zymosan stimulated CL and PMA measurements were performed and the subpopulations of T lymphocyte (CD2⁺, CD4⁺, CD8⁺) were assayed in whole blood. There was no effect of the applied supportive treatment on the value of morphological blood indices. A significant influence of the time of sample collection on the level of CL and dynamics of lymphocytes T subpopulation was demonstrated. A single injection of flunixin meglumine or lysozyme dimer on the day of the beginning of treatment of E. coli mastitis, does not affect the level of neutrophil chemiluminescence and the percentage of T lymphocytes in the blood of mastitic cows in the analysed period of time.

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2013
• Tom: 16
• Numer: 4
• Opis fizyczny: p.671-677,fig.,ref.

Twórcy

autor

Markiewicz H.

• Department of Pathophysiology of Reproduction and Mammary Gland, National Veterinary Research Institute, Al. Powstańców Wlkp. 10, 85-090 Bydgoszcz, Poland

autor

Krumrych W.

• Department of Pathophysiology of Reproduction and Mammary Gland, National Veterinary Research Institute, Al. Powstańców Wlkp. 10, 85-090 Bydgoszcz, Poland

autor

Gehrke M.

• Department of Animal Reproduction and Animal Health Protection, University of Technology and Life Sciences, 85-084 Bydgoszcz, Poland

Bibliografia

• Alluwaimi AM (2004) The cytokines of bovine mammary gland: prospects for diagnosis and therapy. Res Vet Sci 77: 211-222.
• Anderson KL, Kindahl H, Smith AR, Davis LE, Gustafsson BK (1986) Endotoxin-induced bovine mastitis: arachidonic acid metabolites in milk and plasma and effect of flunixin meglumine. Am J Vet Res 47: 1373-1377.
• Burvenich Ch, Van Merris V, Mehrzad J, Diez-Fraile A, Duchateau L (2003) Severity of E. coli mastitis is mainly determined by cow factors. Vet Rec 34: 521-564.
• Carroll EJ, Mueller R, Panico L (1982) Chemotactic factors for bovine leukocytes. Am J Vet Res 43: 1661-1664.
• Cebra CK, Garry FB, Dinsmore RP (1996) Naturally occurring acute coliform mastitis in Holstein cattle. J Vet Intern Med 10: 252-257.
• Dosogne H, Meyer E, Sturk A, van Loon J, Massart-Leën AM, Burvenich C (2002) Effect of enrofloxacin treatment on plasma endotoxin during bovine Escherichia coli mastitis. Inflamm Res 51: 201-205.
• Dosogne H, Burvenich C, Freeman AE, Kehrli Jr ME, Detilleux JC, Sulon J, Beckers JF, Hoeben D (1999) Pregnancy-associated glycoprotein and decreased polymorphonuclear leukocyte function in early post-partum dairy cows. Vet Immunol Immunopathol 67: 47-54.
• Hoeben D, Burvenich C, Heyneman R (1998) Antibiotics commonly used to treat mastitis and respiratory burst of bovine polymorphnuclear leukocytes. J Dairy Sci 81: 403-410.
• Hogan JS, Smith KL (2003) Coliform mastitis. Vet Res 34: 507-519.
• Kiczka W (1994) Od monomeru do dimeru lizozymu. Życie Wet 69: 131-136.
• Kornalijnslijper E, Beerda B, Daemen I, Van Der Werf J, Van Werven T, Niewold T, Rutten V, Noordhuizen-Stassen E (2003) The effect of milk production level on host resistance of dairy cows, as assessed by the severity of experimental Escherichia coli mastitis. Vet Res 34: 721-736.
• Malinowski E, Niewitecki W, Nadolny M, Lassa H, Smulski S (2006) Effect of lysozyme dimer injections on results of intramammary treatment of acute mastitis in cows. Medycyna Wet 62: 1395-1399.
• Malinowski E (2001) Lydium-KLP in treatment and prophylaxis of mastitis. In: Tatcher T (ed) Lysozyme dimer in therapy and prophylaxis of animal diseases. Nika Health Products Publisher, Poznań, pp 14-26.
• Markiewicz H, Malinowski E, Kuźma K, Smulski S, Kaczmarowski M (2006) Activity of neutrophils in the blood of healthy and mastitic cows. Medycyna Wet 62: 1288-1291.
• McDermott CM, Cullor JS, Fenwick BW (1991) Intracellular and extracellular enzymatic deacylation of bacterial endotoxin during localized inflammation induced by Escherichia coli. Infect Immun, 59: 478-485.
• McDougall S, Bryan MA, Tiddy RM (2009) Effect of treatment with the nonsteroidal anti-inflammatory meloxicam on milk production, somatic cell count, probability of re-treatment, and culling of dairy cows with mild clinical mastitis. J Dairy Sci 92: 4421-4431.
• Mehrzad J, Janssen D, Duchateau L, Burvenich C (2008) Increase in Escherichia coli inoculums dose accelerates CD8⁺ T-cell trafficking in the primiparous bovine mammary gland. J Dairy Sci 91: 193-201.
• Mehrzad J, Dosogne H, Vangroenweghe F, Burvenich C (2001) A comparative study of bovine blood and milk neutrophil functions with luminol-dependent chemiluminescence. Luminescence 16: 343-356.
• Paape M, Mehrzad J, Zhao X, Detilleux J, Burvenich C (2002) Defense of the bovine mammary gland by polymorphonuclear neutrophil leukocytes. J Mammary Gland Biol Neoplasia 7: 109-121.
• Pyörälä S(2009) Treatment of mastitis during lactation. Ir Vet J 62: S40-44.
• Pyörälä SH, Pyörälä EO (1998) Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995). J Am Vet Med Assoc 212: 407-412.
• Rantala M, Kaartinen L, Valimaki E, Stryrman M, Hiekkaranta M, Niemi A, Saari L, Pyörälä S(2002) Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. J Vet Pharmacol Ther 25: 251-258.
• Shafer-Weaver KA, Sordillo LM (1997) Bovine CD8⁺ suppressor lymphocytes alter immune responsiveness during the postpartum period. Vet Immunol Immunopathol 56: 53-64.
• Springer HR, Goff JP, Bannerman DD, Paape MJ (2006) Lymphocyte, neutrophil, and mineral responses to S-aureus and E-coli mastitis. J Anim Sci 84: 164.
• Vangroenweghe F, Duchateau L, Burvenich C (2004) Moderate inflammatory reaction during experimental Escherichia coli mastitis in primiparous cows. J Dairy Sci 87: 886-895.
• Van Kampen C, Mallard BA (1997) Effects of peripartum stress and health on circulating bovine lymphocyte subsets. Vet Immunol Immunopathol 59: 79-91.
• Wenz JR, Barrington GM, Garry FB, McSweeney KD, Dinsmore RP, Goodell G, Callan RJ (2001) Bacteremia associated with naturally occurring acute coliform mastitis in dairy cows. J Am Vet Med Assoc 219: 976-981.
• Yeiser EE, Leslie KE, McGilliard ML, Petersson-Wolfe CS (2012) The effects of experimentally induced Escherichia coli mastitis and flunixin meglumine administration on activity measures, feed intake, and milk parameters. J Dairy Sci 95: 4939-4949.
• Young FJ, Fitzpatrick JL, Eckersall PD, Logue DN, Knight CJ, Nolan AM (2000) Recognising and controlling pain and inflammation in bovine mastitis. In: Zecconi A (ed) IDF Symposium on Immunology of Ruminant Mammary Gland, Stresa, pp 345-346.